Global Cerebral and Tissue Oximetry Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Modular Devices and Handheld Devices

By End User;

Clinical, Hospitals, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn705630008 Published Date: May, 2025 Updated Date: July, 2025

Cerebral and Tissue Oximetry Devices Market Overview

Cerebral and Tissue Oximetry Devices Market (USD Million)

Cerebral and Tissue Oximetry Devices Market was valued at USD 6,563.44 million in the year 2024. The size of this market is expected to increase to USD 10,539.45 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.0%.


Global Cerebral and Tissue Oximetry Devices Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 7.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.0 %
Market Size (2024)USD 6,563.44 Million
Market Size (2031)USD 10,539.45 Million
Market ConcentrationMedium
Report Pages394
6,563.44
2024
10,539.45
2031

Major Players

  • Edwards Lifesciences Corp.
  • Hamamatsu Photonics KK
  • HyperMed Imaging, Inc.
  • ISS Inc.
  • Masimo Corp.
  • Medtronic Plc
  • Moor Instruments Ltd.
  • Nonin Medical Inc.
  • Sotera Wireless Inc.
  • Spectros Corp.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Cerebral and Tissue Oximetry Devices Market

Fragmented - Highly competitive market without dominant players


The Cerebral and Tissue Oximetry Devices Market is witnessing strong momentum, driven by the growing need for enhanced intraoperative monitoring. These devices offer real-time, non-invasive measurement of oxygen saturation in the brain and other tissues, significantly reducing surgical risks. With over 60% of hospitals utilizing these technologies, their role in critical care is becoming indispensable.

Technological Integration Enhancing Accuracy
Technological innovations are elevating the performance of cerebral oximeters, particularly their integration with digital health systems and clinical software. This has led to a 48% increase in adoption across neurosurgical and trauma procedures, owing to the benefits of improved precision and automated data capture.

Expanding Use in Pediatric and Cardiac Care
In pediatric and cardiac care, usage is also expanding rapidly. Around 55% of pediatric surgical centers now use cerebral oximetry to enhance neuroprotection, while in cardiac surgery, application rates have surged by 50% to mitigate ischemic complications during bypass procedures.

Growing Preference for Non-Invasive Monitoring
The demand for non-invasive, continuous monitoring is further accelerating market expansion. Healthcare professionals are opting for tissue oximetry devices that eliminate the risks associated with invasive approaches, contributing to a 52% preference rate over conventional techniques.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
  4. Cerebral and Tissue Oximetry Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of neurological disorders
        2. Growing demand for perioperative monitoring
        3. Aging population and rising healthcare expenditure
      2. Restraints
        1. High cost of advanced oximetry devices
        2. Limited reimbursement policies
        3. Integration complexities in healthcare systems
      3. Opportunities
        1. Telehealth and remote patient monitoring
        2. Collaborations with healthcare providers
        3. Development of portable and wearable devices
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Cerebral and Tissue Oximetry Devices Market, By Product, 2021 - 2031 (USD Million)
      1. Modular Devices

      2. Handheld Devices

    2. Cerebral and Tissue Oximetry Devices Market, By End User, 2021 - 2031 (USD Million)
      1. Clinical
      2. Hospitals
      3. Others
    3. Cerebral and Tissue Oximetry Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Edwards Lifesciences Corp.
      2. Hamamatsu Photonics KK
      3. HyperMed Imaging, Inc.
      4. ISS Inc.
      5. Masimo Corp.
      6. Medtronic Plc
      7. Moor Instruments Ltd.
      8. Nonin Medical Inc.
      9. Sotera Wireless Inc.
      10. Spectros Corp.
  7. Analyst Views
  8. Future Outlook of the Market